Last updated on May 2019

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis


Brief description of study

This post-marketing study is designed to compare the safety of tofacitinib versus TNF inhibitor with respect to major cardiovascular adverse events and malignancies, excluding non-melanoma skin cancers when given to subjects with rheumatoid arthritis. Other safety events, including non-melanoma skin cancers, hepatic events, infections, and efficacy parameters will be collected and evaluated in the study.

Clinical Study Identifier: NCT02092467

Find a site near you

Start Over

Tiervlei Trial Centre, Karl Bremer Hospital

Bellville, Cape Town, South Africa
1.39miles
  Connect »

Panorama Medical Centre.

Cape Town, South Africa
2.89miles
  Connect »

Arthritis Clinical Research Trials cc

Cape Town, South Africa
8.04miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.